Claritas Pharmaceuticals, Inc. Share Price
Stocks
CLAZF
CA1806342061
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -.--% |
|
-.--% | - |
| Market Cap | 5.37M 3.82M 3.32M 3.1M 2.85M 364M 5.46M 36.57M 14.32M 182M 14.36M 14.04M 599M | P/E 2019 |
-0.74x | P/E 2020 | 0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 6.29M 4.48M 3.89M 3.63M 3.34M 427M 6.4M 42.84M 16.78M 213M 16.82M 16.45M 702M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
99.74% | Yield 2019 * |
-
| Yield 2020 | - |
| 3 years | 0 |  | 0 |
| 5 years | 0 | | 0.42 |
| 10 years | 0 | | 15.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CEO | Chief Executive Officer | 76 | 20/06/2017 |
Victoria Rudman
DFI | Director of Finance/CFO | 58 | 28/06/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Farrell
CHM | Chairman | 76 | 17/03/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/10/21 | Buy | 118,000 | 0.3332% | |||
| 11/10/21 | Buy | 152,500 | 0.4307% | |||
| 11/10/21 | Buy | 24,500 | 0.0692% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 37 | |
| -0.27% | -0.25% | -1.20% | +13.35% | 48.22B | |
| +3.63% | +2.25% | +405.65% | +502.37% | 38.79B | |
| -2.36% | -6.10% | +24.83% | +5.16% | 38.41B | |
| +1.31% | -4.25% | +3.98% | +56.43% | 34.88B | |
| +1.98% | +3.97% | +13.89% | +40.90% | 29.19B | |
| -0.32% | +0.19% | +32.29% | +121.09% | 16B | |
| -0.98% | -5.05% | - | - | 16.05B | |
| +1.59% | +0.44% | +3.43% | +16.80% | 13.53B | |
| -1.77% | -13.25% | -5.12% | -38.28% | 12.22B | |
| Average | +0.26% | -0.55% | +59.72% | +89.73% | 24.73B | |
| Weighted average by Cap. | +0.47% | +0.21% | +76.43% | +108.92% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -21.21M -15.1M -13.13M -12.25M -11.25M -1.44B -21.58M -144M -56.59M -718M -56.73M -55.47M -2.37B | 4.21M 3M 2.61M 2.43M 2.23M 286M 4.28M 28.68M 11.23M 142M 11.26M 11.01M 470M |
| Net Debt | 704K 501K 436K 407K 373K 47.78M 716K 4.8M 1.88M 23.83M 1.88M 1.84M 78.58M | 920K 655K 569K 531K 488K 62.43M 936K 6.27M 2.45M 31.14M 2.46M 2.41M 103M |
Employees
-
- Stock Market
- Stocks
- CLAZF Stock
Select your edition
All financial news and data tailored to specific country editions
